Skip to main content

TABLE 2 Laboratory data from different groups

From: GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial

 

AH

AHT1

AHT2

 

Retrieved oocytes (Mean ± SD)

< 35 anni

8,7 ± 4,5

9,2 ± 5,3

9,3 ± 4,2

NS

≥35 anni

7,8 ± 4,1

7,6 ± 4,3

7,3 ± 2,9

NS

Inseminated oocytes (Mean ± SD)

< 35 anni

5,2 ± 2,1

5,3 ± 2,4

4,2 ± 1,4

NS

≥35 anni

5,7 ± 2,9

5,9 ± 2,6

6,1 ± 2,4

NS

Embryos obtained (Mean ± SD)

< 35 anni

3,9 ± 1,8

3,9 ± 1,6

3,1 ± 0,9

NS

≥35 anni

4,1 ± 2,2

4,0 ± 2,0

4,2 ± 2,1

NS

Transferred embryos (Mean ± SD)

< 35 anni

1,7 ± 0,6

1,7 ± 0,6

1,5 ± 0,7

NS

≥35 anni

2,2 ± 0,6

2,2 ± 0,7

2,3 ± 0,7

NS

  1. AH Antagonist cycles with only Progesterone in luteal phase
  2. AHT1 Antagonist cycles with addition of luteal triptorelin as multiple injections
  3. AHT2 Antagonist cycles with addition of luteal triptorelin as single bolus